Title:
AIRWAY MUCUS SECRETION INHIBITORS
Document Type and Number:
WIPO Patent Application WO/2002/026229
Kind Code:
A1
Abstract:
Remedies and/or preventives for diseases accompanied by the excessive airway mucus secretion which contain 5-membered heterocyclic compounds represented by the following general formula (I) or nontoxic salts thereof as the active ingredient: (I) wherein Z represents an a-aminocarbonyl-containing group; R?1¿ represents (1) substituted alkyl, alkenyl or alkynyl, (2) OH, (3) amino, (4) alkylamino, (5) dialkylamino, etc.; and X and Y represent each O, S or a substituted N atom.
More Like This:
Inventors:
NAGAI ATSUSHI (JP)
SHIRAJI TAKAMITSU (JP)
SHIRAJI TAKAMITSU (JP)
Application Number:
PCT/JP2001/008569
Publication Date:
April 04, 2002
Filing Date:
September 28, 2001
Export Citation:
Assignee:
ONO PHARMACEUTICAL CO (JP)
NAGAI ATSUSHI (JP)
SHIRAJI TAKAMITSU (JP)
NAGAI ATSUSHI (JP)
SHIRAJI TAKAMITSU (JP)
International Classes:
A61K31/00; A61K31/4245; A61K31/4355; A61K31/4365; A61K31/437; A61K31/4439; A61K31/47; A61K31/4725; A61K31/513; A61K31/5377; A61K31/55; A61K31/551; A61K31/5513; A61P11/06; C07D413/12; C07D487/06; C07D491/048; C07K5/02; C07K5/08; C07K5/083; C07K5/097; (IPC1-7): A61K31/4245; A61K31/4355; A61K31/4365; A61K31/437; A61K31/4439; A61K31/4725; A61K31/513; A61K31/5377; A61K31/55; A61K38/05; A61P11/06
Domestic Patent References:
WO1998024806A2 | 1998-06-11 | |||
WO1996016080A1 | 1996-05-30 | |||
WO2001044214A1 | 2001-06-21 | |||
WO2001040204A1 | 2001-06-07 | |||
WO2000052032A1 | 2000-09-08 | |||
WO1993018059A2 | 1993-09-16 |
Foreign References:
JPH06298663A | 1994-10-25 |
Other References:
CHEMICAL ABSTRACTS, vol. 131, Columbus, Ohio, US; abstract no. 115190, XP002906733
CHEMICAL ABSTRACTS, vol. 124, Columbus, Ohio, US; abstract no. 114174, XP002906732
CHEMICAL ABSTRACTS, vol. 124, Columbus, Ohio, US; abstract no. 114174, XP002906732
Attorney, Agent or Firm:
Ohie, Kunihisa (2-6 Nihonbashi-Ningyocho 2-chome Chuo-ku, Tokyo, JP)
Download PDF:
Previous Patent: BENZIMIDAZOLONE ANTIVIRAL AGENTS
Next Patent: USE OF NITROXIDES FOR THE TREATMENT OF VASCULAR DISORDERS IN A DIABETIC MAMMAL
Next Patent: USE OF NITROXIDES FOR THE TREATMENT OF VASCULAR DISORDERS IN A DIABETIC MAMMAL